Aurobindo Pharma Share Price in Focus; US FDA Completes Inspection at Lannett Company LLC

Aurobindo Pharma announced that it has successfully completed a regular US FDA inspection of the Lannett Company LLC facility in Seymour, Indiana. The inspection lasted from August 17 through to August 21, 2026, as per the exchange filing. 

Lannett Company is a wholly owned indirect subsidiary of Aurobindo Pharma through its intermediary wholly owned subsidiary Aurobindo Pharma USA, Inc.  

Five-Day Inspection in Indiana 

The inspection wasn't part of the routine inspections that took place at Lannett Company's Seymour facility from August 17 through August 21, 2026, according to an announcement by the USFDA.  

The filing provides no additional information regarding the activities subject to inspection. 

About Aurobindo Pharma 

Aurobindo Pharma is a pharmaceutical company based in Hyderabad, with its business spread across generic medicines and active pharmaceutical ingredients.  

It has operations in overseas markets, including the US. Lannett Company is part of the group's US operations through Aurobindo Pharma USA, Inc. 

Read More: Insolation Energy Share Price in Focus; Wins 99 MW Solar Projects From MSEDCL! 

Aurobindo Pharma Share Price Performance  

As of 24 August 2026, at 1:11 PM, Aurobindo Pharma share price is trading at ₹1,628.20 per share, reflecting a surge of 0.43% from the previous trading session. 

Conclusion  

Aurobindo Pharma has disclosed the completion of the routine US FDA inspection at Lannett Company’s Seymour facility. The inspection took place from August 17 to August 21, 2026, with the company reporting the development on August 24. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.  

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.